Industry braces for regulatory reform – how far will the TGA go? by Steve Jones and Adam Sheldon August 7, 2025August 8, 2025 For years now – ever since campaigners celebrated legalisation in 2016 – elements of the established […]
Old wounds reopen as Epsilon demands repayment of funds from former chairman by Steve Jones August 7, 2025August 7, 2025
ODC defends regulatory approach in response to cultivator concerns by Adam Sheldon August 6, 2025August 6, 2025
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
Cann Group closing in on finance restructure as bank balance sinks to $10K by Steve Jones July 31, 2025August 1, 2025
Fresh criticism of prescribing volumes illustrate ‘urgency’ of industry unity by Steve Jones July 31, 2025August 4, 2025
‘You can’t be a shrinking violet in this game’: Spring Sciences Australia prepares for IPO to drive expansion by Steve Jones July 31, 2025July 31, 2025
‘Competing against your customer is never a good thing’: MedTEC drops own brand in pursuit of B2B sales by Steve Jones July 30, 2025July 31, 2025
Can CBD topical relieve arthritis? OMG Pharma prepares for clinical trial in bid to find ‘robust’ evidence of efficacy by Steve Jones July 30, 2025July 30, 2025
